N/A
NPS Score
VS
MyoKardia Claimed Company
- EMPLOYEE
PARTICIPANTS - 2
- TOTAL
RATINGS
PTC Therapeutics
- EMPLOYEE
PARTICIPANTS - 6
- TOTAL
RATINGS
MyoKardia vs PTC Therapeutics
Competitors at MyoKardia is not yet available. Get insights into the competitive rankings of MyoKardia CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
MyoKardia
MyoKardia's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of MyoKardia. Their current market cap is $11.99B.
PTC Therapeutics
PTC Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of PTC Therapeutics. Their current market cap is $3.27B.
4/5
Product Quality
5/5
4/5
Pricing
1.5/5
4/5
Customer Service
4/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 100
See how MyoKardia compares to its competitors
Working at MyoKardia vs Working at PTC Therapeutics
Not enough ratings
CEO Rating
76 / 100
CEO Rating
Winner
MyoKardia
MyoKardia doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
PTC Therapeutics
Employees at PTC Therapeutics rate their CEO, Stuart Peltz, 76/100.